PMID: 9418253Jan 7, 1998Paper

Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica Typhimurium DT104

FEMS Microbiology Letters
D SandvangL B Jensen

Abstract

The presence and genetic content of integrons was investigated in eight Salmonella enterica Typhimurium DT104 isolates from different pig herds in Denmark. Two different integrons were identified using PCR and sequencing. Each of the integrons carried a single resistance cassette in addition to the sul1 and qacE delta 1 genes characteristic of integrons. The first integron encoded the ant (3")-Ia gene that specified resistance to spectinomycin and streptomycin. The second contained the pse-1 beta-lactamase gene. All the multiresistant strains contained both integrons. The presence of these two integrons did not account for the total phenotypic resistance of all the isolates and does not exclude the presence of other mobile DNA elements.

References

Sep 1, 1992·Antimicrobial Agents and Chemotherapy·M T Zühlsdorf, B Wiedemann
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·P Huovinen, G A Jacoby
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K J BreslauerL A Marky
Dec 1, 1995·Microbiology·G D Recchia, R M Hall
Oct 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·B SallenC Mabilat

❮ Previous
Next ❯

Citations

Sep 12, 2002·International Journal of Food Microbiology·Henning Sørum, Trine Marie L'Abée-Lund
May 19, 2001·Microbes and Infection·W RabschA J Bäumler
Oct 6, 1999·Current Opinion in Microbiology·D A Rowe-Magnus, D Mazel
Jul 18, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Stefano MorabitoAlessandra Carattoli
Nov 25, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·J IversenA Dalsgaard
Jun 27, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·D Sandvang, F M Aarestrup
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·José Di ConzaGabriel Gutkind
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Alessandra CarattoliIda Luzzi
Aug 23, 2011·Applied and Environmental Microbiology·Maria KarczmarczykSéamus Fanning
Sep 6, 2003·Journal of Clinical Microbiology·Malthe A Melau KristiansenThorkild Bremholm Rasmussen
Mar 7, 2006·Journal of Clinical Microbiology·François-Xavier WeillPatrick A D Grimont
May 11, 2013·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Shu-Ching HuangYao-Jong Yang
Dec 1, 2011·Research in Microbiology·Alexandra MouraAntónio Correia
Jan 11, 2012·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Thiago Pavoni Gomes ChagasMarise Dutra Asensi
Oct 19, 2007·Biochimica Et Biophysica Acta·Denice C BayRaymond J Turner
Nov 10, 2011·FEMS Immunology and Medical Microbiology·Farzaneh FiroozehMohammad M Aslani
Sep 6, 2002·Animal Biotechnology·P F McDermottD G White
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hsin-Yun SunShen-Wu Ho
Nov 28, 2006·Animal Biotechnology·H HarbottleD G White

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.